Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the immune landscape of primary tumours versus metastases in pancreatic cancer using immunohistochemistry and transcriptomic profiling
EF 2017-18
Résumé
Pancreatic cancer, which commonly presents as advanced, metastatic disease, continues to have the lowest overall 5-year survival of all malignancies, and is unresponsive to novel immunotherapies, which has proven beneficial in other cancers. The types of immune cells that infiltrate tumours are gaining recognition as key factors preventing successful antitumour immunity. Cytokines, important immune signalling molecules, have garnered increased attention in tumour biology, due to their effect in modifying this immune cell infiltrate. It remains unknown which cytokines are released by established metastatic cells in patients, and what effect this has in recruiting immune cells into liver metastases, the most common metastatic site for patients with pancreatic cancer. Using RNA sequencing, immunohistochemistry and advanced image analysis software, we will analyze the expression of cytokines from a large sample of primary and metastatic tumours from pancreatic cancer patients, and determine if this corresponds with the immune cell landscape in the adjacent tumour regions. We will assess if these signatures correlate with other metrics including indicators of antitumour immunity, tumour stating, and overall patient survival. Understanding the immune landscape in primary tumours and metastases will augment the knowledge of tumour resistance to immunotherapies and yield novel treatments for patients suffering from this disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386432
Name
Romero Joan Miguel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the immune landscape of primary tumours versus metastases in pancreatic cancer using immunohistochemistry and transcriptomic profiling
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Image Analysis; Immuno-Oncology; Immunohistochemistry; Liver Metastases Analysis; Pancreatic Cancer; Primary Tumour Analysis; Rna-Seq Analysis; Translational; Tumour Microenvironment
Abstract
Pancreatic cancer, which commonly presents as advanced, metastatic disease, continues to have the lowest overall 5-year survival of all malignancies, and is unresponsive to novel immunotherapies, which has proven beneficial in other cancers. The types of immune cells that infiltrate tumours are gaining recognition as key factors preventing successful antitumour immunity. Cytokines, important immune signalling molecules, have garnered increased attention in tumour biology, due to their effect in modifying this immune cell infiltrate. It remains unknown which cytokines are released by established metastatic cells in patients, and what effect this has in recruiting immune cells into liver metastases, the most common metastatic site for patients with pancreatic cancer. Using RNA sequencing, immunohistochemistry and advanced image analysis software, we will analyze the expression of cytokines from a large sample of primary and metastatic tumours from pancreatic cancer patients, and determine if this corresponds with the immune cell landscape in the adjacent tumour regions. We will assess if these signatures correlate with other metrics including indicators of antitumour immunity, tumour stating, and overall patient survival. Understanding the immune landscape in primary tumours and metastases will augment the knowledge of tumour resistance to immunotherapies and yield novel treatments for patients suffering from this disease.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Romero, Joan Miguel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~